Cellular effects of HER3-specific affibody molecules.
Recent studies have led to the recognition of the epidermal growth factor receptor HER3 as a key player in cancer, and consequently this receptor has gained increased interest as a target for cancer therapy. We have previously generated several Affibody molecules with subnanomolar affinity for the H...
Main Authors: | Lovisa Göstring, Magdalena Malm, Ingmarie Höidén-Guthenberg, Fredrik Y Frejd, Stefan Ståhl, John Löfblom, Lars Gedda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3386944?pdf=render |
Similar Items
-
Cellular Studies of HER-family Specific Affibody Molecules
by: Göstring, Lovisa
Published: (2011) -
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01) -
Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
by: Malm, Magdalena, et al.
Published: (2013) -
Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
by: Magdalena Malm, et al.
Published: (2013-01-01) -
Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01)